Page 32 - Patrick Wingrove News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week, suggesting a new supply challenge for the popular medicine. Wegovy is a weekly injection that can help patients shed 15% of their weight alongside diet and exercise changes. Walgreens, one of the biggest U.S. pharmacies, is experiencing supply shortages for the higher strengths, spokesperson Erin Loverher confirmed.

By Maggie Fick, Patrick Wingrove and Elissa Welle LONDON/NEW YORK (Reuters) - Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy...

Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week, suggesting a new supply challenge for the popular medicine. Wegovy is a weekly injection that can help patients shed 15% of their weight alongside diet and exercise changes. Walgreens, one of the biggest U.S. pharmacies, is experiencing supply shortages for the higher strengths, spokesperson Erin Love

By Patrick Wingrove (Reuters) - Americans without health insurance pay an average of $98 for Eli Lilly's generic insulin despite the company's May 1 p...

By Patrick Wingrove (Reuters) - Americans without health insurance pay an average of $98 for Eli Lilly's generic insulin despite the company's May 1 p...